# SEPSIS AND SHOCK

<table><colgroup><col> <col></colgroup><tbody><tr><td colspan="2"><p><b>定義</b> <span>(<i>JAMA</i> 2016;315:801; 2017;317:290 &amp; 301)</span></p></td></tr><tr><td><p><b>Sepsis</b></p></td><td><p>Life-threatening organ dysfxn (SOFA Δ ≥2) due to infection</p><p>Quick SOFA (qSOFA): ≥2 of the following: RR ≥22, ΔMS, SBP ≤100 mmHg</p></td></tr><tr><td><p><b>Septic shock</b></p></td><td><p>Sepsis-induced circulatory and cellular/metabolic abnormalities severe enough to ↑ mortality; hypotension requiring pressors for MAP ≥65 and lactate &gt;2 despite adequate fluid resuscitation</p></td></tr><tr><td colspan="2"><p><b>Sequential Organ Failure Assessment (SOFA):</b> ↑ points for worsening organ dysfxn: respiration (↓ P:F ratio); coag (↓ plt); liver (↑ bili); CV (↓ MAP or ↑ pressors); CNS (↓ GCS); renal (↑ Cr or ↓ UOP)</p></td></tr></tbody></table>

**Systemic inflammatory response syndrome (SIRS):** ≥2 of the following: (1) Temp >38 or <36°C, (2) HR >90, (3) RR >20 or PaCO2 <32, (4) WBC >12k or <4k or >10% bands. No longer used.

### Shock (see “PA Catheter & Tailored Therapy” for subtypes; _NEJM_ 2013;369:1726)

• Tissue hypoxia due to ↓ tissue perfusion and hence ↓ tissue O2 delivery and/or ↑ O2 consumption or inadequate O2 utilization

• Typical signs include HoTN (SBP <90 mmHg or drop in SBP >40 mmHg), tachycardia, oliguria (UOP <0.5 cc/kg/h), Δ mentation, metabolic acidosis ± ↑ lactate

• Hard to dx as ↑ SVR can maintain SBP, but tissue perfusion poor; shock index (HR/SBP) >0.9 and pulse pressure \[(SBP – DBP)/SBP\] <25% clues to significant shock

# MANAGEMENT

### Fluids

• Aggressive IV fluid resuscitation (30 mL/kg) admin in boluses within 3 h of presentation

• Crystalloid as good as colloid for resuscitation (_JAMA_ 2013;310:1809; _NEJM_ 2014;370:1412)

• Balanced crystalloid (LR, Plasma-Lyte) ↓ rate of major kidney events (composite of death, need for RRT, or persistent renal dysfxn) compared with NS (_NEJM_ 2018;378:829)

• NaHCO3 may ↓ mortality & need for RRT if AKI & pH <7.2 (_Lancet_ 2018;392:31)

• Predictors of fluid responsiveness: pulse pressure variation >13% with respiration (_Chest_ 2008;133:252); resp. variation in IVC diam, or >10% ↑ in pulse pressure with passive leg raise. Static CVP poor surrogate.

• After early resuscitation, if ALI/ARDS, target CVP 4–6 mmHg because additional fluids may be harmful → ↑ ventilator/ICU days (_NEJM_ 2006;354:2564; _Chest_ 2008;133:252)

### Pressors & inotropes (also see “ICU Medications”)

• MAP target 65–70 mmHg as good as 80–85 and ↓ AF (_NEJM_ 2014;370:1583)

• Norepinephrine: ↓ arrhythmia & mortality c/w dopamine (_NEJM_ 2010;362:779; _Crit Care Med_ 2012;40:725) and ∴ is pressor of choice in septic shock

• Vasopressin: adding to norepi (vs. using high-dose norepi) ↓ risk of AF & RRT by ~¼ (_JAMA_ 2018;319:1889)

• If targets (see below) not reached after adequate fluids and pressors, consider inotropes

### Targets

• Lactate clearance (≥20%/2 h) as effective as ScvO2 to guide resusc. (_JAMA_ 2010;303:739)

• Targeting capillary refill time ≤3 sec (check q30min) as good if not better than lactate clearance (_JAMA_ 2019;321:654)

### Antibiotics

• Start empiric IV 抗生素 as soon as possible following recognition of severe sepsis or septic shock; every hr delay in 抗生素 admin a/w 7.6% ↑ in mortality (_Crit Care Med_ 2006;34:1589), 抗生素 admin within 3 h of presentation in the ED a/w ↓ in-hospital mortality (_NEJM_ 2017;376:2235)

• If possible, obtain 2 sets of BCx before urgently starting 抗生素 (but do not delay 抗生素)

• Broad gram-positive (incl MRSA) & gram-neg (incl highly resistant) coverage, ± anaerobes

• Procalcitonin-guided _cessation_ (not initiation) ↓ mortality (_Crit Care Med_ 2018;46:684)

• Empiric micafungin in critically ill 病人 with Candida colonization & sepsis of unknown etiology ↓ invasive fungal infxns & tended ↑ invasive fungal infxn-free survival, espec. in 病人 with 1,3-b-D-glucan >80 (_JAMA_ 2016;316:1555)

### Steroids (_Crit Care Med_ 2018;46:1411)

• Hydrocortisone 50 mg IV q6 + fludrocortisone 50 µg via NGT daily in septic shock ↓ duration of shock and may ↓ mortality (_NEJM_ 2018; 378:797 & 809)

• Consider in 病人 with refractory shock on escalating doses of pressors

### Early Goal-Directed Therapy (EGDT)

• Historically: IVF & pressors for MAP ≥65 mmHg, CVP 8–12 mmHg, UOP ≥0.5 mL/kg/h; inotropes & PRBCs for ScvO2 ≥70% in 6 h (_NEJM_ 2001;345:1368)

• However, now in era of early 抗生素 and adequate fluid resuscitation, no ↓ in mortality with EGDT vs. current usual care, and ↑ hospital costs (_NEJM_ 2017; 376:2223)
